The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes?

GUYMON – As part of their mission to expand access to oral health care across Oklahoma, the University of Oklahoma College of Dentistry and the Oklahoma Dental Foundation (ODF) have launched a mobile dental clinic in Guymon, offering services for patients of all ages. The clinic, a key program of ODF, is stationed in the parking area of Memorial Hospital of Texas County.

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma Health Stephenson Cancer Center. The treatment offers potential hope for patients whose tumors lack a key DNA repair protein called ATM.

For more than 35 years, University of Oklahoma Health Campus researchers have played a key role in the Strong Heart Study, a landmark project that has uncovered critical insights into cardiovascular disease among American Indian communities. Today, it remains the most extensive and longest-running study of its kind in the United States.

Abdul Rafeh Naqash, M.D., associate professor at the University of Oklahoma College of Medicine and an oncologist at OU Health Stephenson Cancer Center, has been named a fellow of the American Society of Clinical Oncology (FASCO).